Risk Factors of the Revisit of the Adult Heart Failure Patients in Emergency Department Siriraj Hospital

June 14, 2011 updated by: Mahidol University

Risk Factors of the Revisit of the Adult Heart Failure Patients in Emergency Department in Siriraj Hospital: The One Year Period.

To identify the risk factors of the revisit of the adult HF patients in emergency department.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Because heart failure (HF) is the leading cause of hospitalization and readmission in many hospitals worldwide.

Identifying the risk factors of these HF patients in emergency department is the important reason for the proper management of the HF patients in the future. And can reduce number of hospitalization and readmission in our hospital.

Study Type

Observational

Enrollment (Actual)

533

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Thailand
      • Bangkok, Thailand, 10700
        • Emergency department, Siriraj hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Medical records of 533 patients,who visited the emergency department with the diagnosis of HF (ICD-10 I500, I501 and I509) in the period from 1st Jan 2008 to 31st Dec 2008, were reviewed.

Description

Inclusion Criteria:

  • Patients age from 18 years old
  • Patients who were diagnosed HF by the Framingham's criteria10
  • Patients who were discharged home from emergency department

Exclusion Criteria:

  • Patients age less than 18 years old
  • Patients who not met Framingham's criteria, needed hospital admission, were referred to other hospital, and death

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Revisit
HF patients who revisit the emergency department before the next appointment date.
Other: Patient charts reviewing
Reviewing chart and identifying risk factors
Non-revisit
HF patients who follow up on the appointment date.
Other: Patient charts reviewing
Reviewing chart and identifying risk factors

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of HF patients who were revisited emergency department before the appointment date.
Time Frame: 1 year
All HF-peatient charts were reviewed and divided in revisit group and non revisit group.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Characteristics of the patients in revisit group
Time Frame: 1 year
The Characteristics of the patients in both groups such as underlying diseases, ejection fraction, and time for treating in emergency department. The results were compared to find the relation between both groups.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mahidol University

Investigators

  • Principal Investigator: Phuriphong Songarj, MD, Department of Anesthesiology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2009

Primary Completion (Actual)

September 1, 2009

Study Completion (Actual)

February 1, 2010

Study Registration Dates

First Submitted

June 9, 2011

First Submitted That Met QC Criteria

June 14, 2011

First Posted (Estimate)

June 15, 2011

Study Record Updates

Last Update Posted (Estimate)

June 15, 2011

Last Update Submitted That Met QC Criteria

June 14, 2011

Last Verified

June 1, 2011

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 740/2551(EC1)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Renal Insufficiency

Clinical Trials on Patient charts reviewing

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe